PH15382A - Semi-synthetic 4-sulfonylamino-oleandomycin derivatives - Google Patents

Semi-synthetic 4-sulfonylamino-oleandomycin derivatives

Info

Publication number
PH15382A
PH15382A PH21053A PH21053A PH15382A PH 15382 A PH15382 A PH 15382A PH 21053 A PH21053 A PH 21053A PH 21053 A PH21053 A PH 21053A PH 15382 A PH15382 A PH 15382A
Authority
PH
Philippines
Prior art keywords
sulfonylamino
semi
synthetic
oleandomycin derivatives
oleandomycin
Prior art date
Application number
PH21053A
Inventor
Arthur Adam Nagel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/883,608 external-priority patent/US4136253A/en
Application filed by Pfizer filed Critical Pfizer
Publication of PH15382A publication Critical patent/PH15382A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH21053A 1977-05-11 1978-04-25 Semi-synthetic 4-sulfonylamino-oleandomycin derivatives PH15382A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79585077A 1977-05-11 1977-05-11
US05/883,608 US4136253A (en) 1977-05-11 1978-03-06 Semi-synthetic 4"-sulfonylamino-oleandomycin derivatives

Publications (1)

Publication Number Publication Date
PH15382A true PH15382A (en) 1982-12-17

Family

ID=27121658

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21053A PH15382A (en) 1977-05-11 1978-04-25 Semi-synthetic 4-sulfonylamino-oleandomycin derivatives

Country Status (31)

Country Link
JP (1) JPS53149990A (en)
AR (1) AR219529A1 (en)
AT (1) AT357263B (en)
AU (1) AU500587B1 (en)
CA (1) CA1098123A (en)
CH (1) CH631461A5 (en)
CS (1) CS199728B2 (en)
DD (1) DD135907A5 (en)
DE (1) DE2820411C2 (en)
DK (1) DK148845C (en)
EG (1) EG13371A (en)
ES (1) ES469648A1 (en)
FI (1) FI67709C (en)
FR (1) FR2390453A1 (en)
GB (1) GB1590162A (en)
GR (1) GR70056B (en)
HU (1) HU180279B (en)
IE (1) IE46839B1 (en)
IL (1) IL54688A (en)
IT (1) IT1094816B (en)
LU (1) LU79638A1 (en)
NL (1) NL174254C (en)
NO (1) NO145384C (en)
NZ (1) NZ187229A (en)
PH (1) PH15382A (en)
PL (1) PL111988B1 (en)
PT (1) PT68019B (en)
RO (1) RO75819A (en)
SE (1) SE446340B (en)
SU (1) SU860707A1 (en)
YU (1) YU40963B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin

Also Published As

Publication number Publication date
FI781478A (en) 1978-11-12
DK205878A (en) 1978-11-12
DK148845B (en) 1985-10-21
IT1094816B (en) 1985-08-10
JPS53149990A (en) 1978-12-27
FR2390453A1 (en) 1978-12-08
LU79638A1 (en) 1979-12-06
NL174254C (en) 1984-05-16
YU40963B (en) 1986-08-31
ES469648A1 (en) 1979-09-16
CS199728B2 (en) 1980-07-31
AR219529A1 (en) 1980-08-29
GB1590162A (en) 1981-05-28
NO145384C (en) 1982-03-10
ATA338978A (en) 1979-11-15
SE446340B (en) 1986-09-01
RO75819A (en) 1981-04-30
PL206687A1 (en) 1979-04-23
IE780953L (en) 1978-11-11
EG13371A (en) 1981-06-30
YU108278A (en) 1983-01-21
NZ187229A (en) 1980-02-21
PT68019B (en) 1979-10-24
GR70056B (en) 1982-07-26
AU500587B1 (en) 1979-05-24
IL54688A0 (en) 1978-07-31
FR2390453B1 (en) 1980-07-04
CA1098123A (en) 1981-03-24
SE7804080L (en) 1978-11-12
HU180279B (en) 1983-02-28
IT7823229A0 (en) 1978-05-10
SU860707A1 (en) 1981-08-30
AT357263B (en) 1980-06-25
FI67709B (en) 1985-01-31
IE46839B1 (en) 1983-10-05
DE2820411A1 (en) 1978-11-16
DE2820411C2 (en) 1983-05-11
NO145384B (en) 1981-11-30
NO781656L (en) 1978-11-14
JPS5633400B2 (en) 1981-08-03
DD135907A5 (en) 1979-06-06
IL54688A (en) 1982-01-31
DK148845C (en) 1986-04-14
FI67709C (en) 1985-05-10
NL7805007A (en) 1978-11-14
PL111988B1 (en) 1980-09-30
NL174254B (en) 1983-12-16
PT68019A (en) 1978-06-01
CH631461A5 (en) 1982-08-13

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
GB1557019A (en) Metalsulphonamido-benzamide derivatives
GB2008579B (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
MY8400370A (en) Prostanol derivatives
PH14637A (en) Oxadiazolopyrimidine derivatives
GB2005261B (en) 2-oxazolydone derivatives
PH13915A (en) Chinazoline derivatives
IL56042A0 (en) Prostanglandin derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
PH15376A (en) 5-phenyl-1h-3-benzazepine derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2008119B (en) Arylsteroid derivatives
PH15382A (en) Semi-synthetic 4-sulfonylamino-oleandomycin derivatives
AU4129978A (en) Eburnamenine derivatives
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives
GB2060630B (en) Pyrazinoquinoline derivatives